Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
Abstract
Cancer is one of the most deadly diseases in the world. Although advances in the field of chemo-preventive and therapeutic medicine have been made regularly over the last ten years, the search for novel anticancer treatments continues. In this field, the marine environment, with its rich variety of organisms, is a largely untapped source of novel compounds with potent antitumor activity. Although many reviews of marine anticancer compounds have been published, we focus here on selected marine compounds that act on the six hallmarks of cancer presented namely self-sufficiency in growth signals, insensitivity to anti-growth signals, evasion of apoptosis, limitless replication, sustained angiogenesis and tissue invasion and metastasis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cancer preventive compounds may stimulate anticancer immunity, inhibit inflammation, angiogenesis and tumor invasion, or protect from UV-radiation damage.
“Cancer preventive compounds may stimulate anticancer immunity, inhibit inflammation, angiogenesis and tumor invasion, or protect from UV-radiation damage [144,145,146,147].”
From Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects (2013) · cites this paper as [147]
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857 · see citing works
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471 · see citing works
Natural products as sources of new drugs over the last 25 years
Newman, D. J., & Cragg, G. M. (2007) · Journal of Natural Products · doi:10.1021/np068054v · Cited by 5,517 · see citing works
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182 · see citing works
Faulkner, D. J. (1990) · Natural Product Reports · doi:10.1039/np9900700269 · Cited by 4,880 · see citing works
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766 · see citing works
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513 · see citing works
Wang, C.-Y., Mayo, M., Korneluk, R., Goeddel, D., & Baldwin, A. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,950 · see citing works
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,882 · see citing works
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc776 · Cited by 2,073 · see citing works
Microtubule-binding agents: a dynamic field of cancer therapeutics
Dumontet, C., & Jordan, M. A. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3253 · Cited by 1,730 · see citing works
Willis, S. N., Chen, L., Dewson, G., Wei, A. H., Naik, E., Fletcher, J. I., Adams, J. M., & Huang, D. C. S. (2005) · Genes & Development · doi:10.1101/gad.1304105 · Cited by 1,236 · see citing works
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,118 · see citing works
Targeting the Cell Cycle: A New Approach to Cancer Therapy
Schwartz, G. K., & Shah, M. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5594 · Cited by 816 · see citing works
Apoptosis and cancer: mutations within caspase genes
Ghavami, S., Hashemi, M. M., Ande, S. R., Yeganeh, B., Xiao, W., Eshraghi, M., Bus, C., Kadkhoda, K., Wiecheć, E., Halayko, A. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066944 · Cited by 712 · see citing works
(2000) · PubMed · Cited by 706 · see citing works
BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
Claudio, E., Brown, K., Park, S., Wang, H., & Siebenlist, U. K. (2002) · Nature Immunology · doi:10.1038/ni842 · Cited by 694 · see citing works
The odyssey of marine pharmaceuticals: a current pipeline perspective
Mayer, A. M. S., Glaser, K. B., Cuevas, C., Jacobs, R. S., Kem, W. R., Little, R. D., McIntosh, J. M., Newman, D. J., Potts, B. C. M., & Shuster, D. E. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.005 · Cited by 669 · see citing works
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet
Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J., & Vandenabeele, P. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401088 · Cited by 665 · see citing works
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565 · see citing works
Stehlik, C., de Martin, R., Kumabashiri, I., Schmid, J. A., Binder, B. R., & Lipp, J. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.1.211 · Cited by 532 · see citing works
Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death
Lorenzo, H. K., Susín, S. A., Penninger, J. M., & Kroemer, G. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400527 · Cited by 508 · see citing works
Cancer Prevention With Natural Compounds
Gullett, N. P., Amin, A. R. M. R., Bayraktar, S., Pezzuto, J. M., Shin, D. M., Khuri, F. R., Aggarwal, B. B., Surh, Y., & Küçük, Ö. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.06.014 · Cited by 490 · see citing works
Glycogen synthase kinase 3: more than a namesake
Rayasam, G. V., Tulasi, V. K., Sodhi, R., Davis, J. A., & Ray, A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00085.x · Cited by 485 · see citing works
Structural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 480 · see citing works
Apoptosis pathways in cancer and cancer therapy
Debatin, K. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0474-8 · Cited by 477 · see citing works
Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).
Iademarco, M. F., McQuillan, J. J., Rosen, G., & Dean, D. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42004-2 · Cited by 473 · see citing works
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2010) · Natural Product Reports · doi:10.1039/c005001f · Cited by 472 · see citing works
Maddika, S., Ande, S. R., Panigrahi, S., Paranjothy, T., Węglarczyk, K., Zuse, A., ESHRAGHI, M., Manda, K., Wiecheć, E., & Łoś, M. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.01.003 · Cited by 460 · see citing works
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
D’Incalci, M., & Galmarini, C. M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0263 · Cited by 446 · see citing works
CD40 regulates the processing of NF‐κB2 p100 to p52
Coope, H. J., Atkinson, P. G. P., Huhse, B., Belich, M. P., Janzen, J., Holman, M. J., Klaus, G. G. B., Johnston, L. H., & Ley, S. C. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf542 · Cited by 442 · see citing works
Derenne, S., Monia, B. P., Dean, N. M., Taylor, J. K., Rapp, M.-J., Harousseau, J., Bataille, R., & Amiot, M. (2002) · Blood · doi:10.1182/blood.v100.1.194 · Cited by 429 · see citing works
Ohmori, Y., Schreiber, R. D., & Hamilton, T. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14899 · Cited by 413 · see citing works
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
Schimmer, A. D., Welsh, K., Pinilla, C., Wang, Z., Krajewska, M., Bonneau, M.-J., Pedersen, I. M., Kitada, S., Scott, F. L., Bailly‐Maitre, B., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00332-5 · Cited by 411 · see citing works
Blunt, J. W., Copp, B. R., Munro, M. H. G., Northcote, P. T., & Prinsep, M. R. (2010) · Natural Product Reports · doi:10.1039/b906091j · Cited by 406 · see citing works
NF-κB and cancer: how intimate is this relationship
Prasad, S., Ravindran, J., & Aggarwal, B. B. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0267-2 · Cited by 389 · see citing works
Marine Biodiversity in the Caribbean: Regional Estimates and Distribution Patterns
Miloslavich, P., Díaz, J. M., Klein, E., Alvarado, J. J., Díaz, C., Gobin, J., Escobar-Briones, E. G., Cruz‐Motta, J. J., Weil, E. F., Cortés, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011916 · Cited by 385 · see citing works
The p53 tumor suppressor participates in multiple cell cycle checkpoints
Giono, L. E., & Manfredi, J. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20689 · Cited by 326 · see citing works
Sutherland, M. K., Sanderson, R. J., Gordon, K. A., Andreyka, J. B., Cerveny, C. G., Yu, C., Lewis, T. S., Meyer, D. L., Zabinski, R. F., Doronina, S. O., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510026200 · Cited by 296 · see citing works
XIAP Induces NF-κB Activation via the BIR1/TAB1 Interaction and BIR1 Dimerization
Lu, M., Lin, S., Huang, Y., Kang, Y. J., Rich, R. L., Lo, Y.-C., Myszka, D. G., Han, J., & Wu, H. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.006 · Cited by 290 · see citing works
Daugan, A., Grondin, P., Ruault, C., de Gouville, A. L. M., Coste, H., Linget, J. M., Kirilovsky, J., Hyafil, F., & Labaudinière, R. F. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0300577 · Cited by 284 · see citing works
Cho, J., & Johnson, G. V. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02155.x · Cited by 282 · see citing works
Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi
Li, W., Srinivasula, S. M., Chai, J., Li, P., Wu, J., Zhang, Z., Alnemri, E. S., & Shi, Y. (2002) · Nature Structural Biology · doi:10.1038/nsb795 · Cited by 277 · see citing works
Kuznetsov, G., Towle, M. J., Cheng, H., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1169 · Cited by 269 · see citing works
Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action
Erba, E., Bergamaschi, D., Bassano, L., Damia, G., Ronzoni, S., Faircloth, G. T., & D'Incalci, M. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00357-9 · Cited by 262 · see citing works
Nicholson, B., Lloyd, G. K., Miller, B., et al. (2005) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000182745.01612.8a · Cited by 260 · see citing works
Antineoplastic agents. 257. Isolation and structure of spongistatin 1
Pettit, G. R., Chicacz, Z. A., Gao, F., et al. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00058a004 · Cited by 260 · see citing works
Aichberger, K. J., Mayerhofer, M., Krauth, M., Skvara, H., Florian, S., Sonneck, K., Akgul, C., Derdak, S. V., Pickl, W. F., Wacheck, V., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0749 · Cited by 256 · see citing works
Sun, X.-M., Bratton, S. B., Butterworth, M., MacFarlane, M., & Cohen, G. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109893200 · Cited by 237 · see citing works
Development of Novel Drugs from Marine Surface Associated Microorganisms
Penesyan, A., Kjelleberg, S. J., & Egan, S. (2010) · Marine Drugs · doi:10.3390/md8030438 · Cited by 235 · see citing works
Huang, Y. (2001) · Cell · doi:10.1016/s0092-8674(02)02075-5 · Cited by 233 · see citing works
Chan, H. L., Bartos, D., & Owen‐Schaub, L. B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2098 · Cited by 229 · see citing works
What are the hallmarks of cancer?
Lazebnik, Y. A. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2827 · Cited by 227 · see citing works
Park, M., & Lee, S. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.060 · Cited by 213 · see citing works
Qin, Z., Chen, R., Wang, Y., Nakai, M., Chuang, D., & Chase, T. N. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-10-04023.1999 · Cited by 211 · see citing works
Sesquiterpene Antitumor Agents: Inhibitors of Cellular Metabolism
Lee, K., Hall, I. H., Mar, E., Starnes, C. O., Elgebaly, S. A., Waddell, T. G., Hadgraft, R. I., Ruffner, C. G., & Weidner, I. (1977) · Science · doi:10.1126/science.191909 · Cited by 210 · see citing works
Michels, J., Johnson, P., & Packham, G. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.007 · Cited by 207 · see citing works
Miller, C. P., Ban, K., Dujka, M. E., McConkey, D. J., Munsell, M., Palladino, M. A., & Chandra, J. (2007) · Blood · doi:10.1182/blood-2006-03-013128 · Cited by 204 · see citing works
Radisky, D. C., Radisky, E. S., Barrows, L. R., Copp, B. R., Kramer, R. A., & Ireland, C. M. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00058a003 · Cited by 203 · see citing works
Genomic Organization of Human and Mouse Genes for Vascular Endothelial Growth Factor C
Chilov, D., Kukk, E., Taira, S., Jeltsch, M., Kaukonen, J., Palotie, A. V., Joukov, V., & Alitalo, K. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25176 · Cited by 203 · see citing works
Ebada, S. S., Lin, W., & Proksch, P. (2010) · Marine Drugs · doi:10.3390/md8020313 · Cited by 177 · see citing works
Bioactive bromopyrrole metabolites from the Caribbean sponge Agelas conifera
Keifer, P. A., Schwartz, R. E., Koker, M. E. S., et al. (1991) · The Journal of Organic Chemistry · doi:10.1021/jo00009a008 · Cited by 176 · see citing works
SANTORO, M. G., Garaci, E., & Amici, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8407 · Cited by 169 · see citing works
Nakagawa, R., Motoki, K., Ueno, H., et al. (1998) · PubMed · Cited by 165 · see citing works
GSH extrusion and the mitochondrial pathway of apoptotic signalling
Coppola, S., & Ghibelli, L. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280056 · Cited by 159 · see citing works
Cuadrado, A., García‐Fernández, L., González, L., Suárez, Y., Losada, A., Alcaide, V., Martı́nez, T., Fernández-Sousa, J. M., Sánchez-Puelles, J.-M., & Múñoz, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201010200 · Cited by 157 · see citing works
Villa, F. A., & Gerwick, L. G. (2010) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923970903296136 · Cited by 155 · see citing works
Hamann, M. T., Alonso, D. A., Martı́n-Aparicio, E., Fuertes, A., Perez-Puerto, M. J., Castro, A., Morales, S., Navarro, M. L., del Monte-Millán, M., Medina, M., et al. (2007) · Journal of Natural Products · doi:10.1021/np060092r · Cited by 154 · see citing works
Wei, S., Dong, K., Fang, L., Wang, X., Li, B., Shen, J., Zhang, Q., Wang, R., & Zhang, H. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0697-7 · Cited by 150 · see citing works
Warabi, K., Matsunaga, S., van Soest, R. W. M., et al. (2003) · The Journal of Organic Chemistry · doi:10.1021/jo0267910 · Cited by 140 · see citing works
Trujillo, J. I., Meyers, M. J., Anderson, D. R., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.070 · Cited by 137 · see citing works
An Overview of Marine Biodiversity in United States Waters
Fautin, D. G., Dalton, P. D., Incze, L. S., Leong, J. C., Pautzke, C., Rosenberg, A. A., Sandifer, P. A., Sedberry, G. R., Tunnell, J. W., Abbott, I. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011914 · Cited by 135 · see citing works
Inhibition of GSK‐3β activity attenuates proliferation of human colon cancer cells in rodents
Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., Ooi, A., Kawakami, K., & Minamoto, T. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00545.x · Cited by 132 · see citing works
Bai, R., Cichacz, Z. A., Herald, C. L., et al. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13253-7 · Cited by 129 · see citing works
Some Marine Ecological Phenomena: Chemical Basis and Biomedical Potential
Scheuer, P. J. (1990) · Science · doi:10.1126/science.2183350 · Cited by 120 · see citing works
Ageliferins, potent actomyosin Atpase activators from the Okinawan marine sponge sp
Kobayashi, J., Tsuda, M., Murayama, T., et al. (1990) · Tetrahedron · doi:10.1016/s0040-4020(01)87756-5 · Cited by 117 · see citing works
Total Syntheses of the Telomerase Inhibitors Dictyodendrin B, C, and E
Fürstner, A., Domostoj, M. M., & Scheiper, B. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0617800 · Cited by 109 · see citing works
Apoptin, a tumor-selective killer
Łos, M. J., Panigrahi, S., Rashedi, I., et al. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.002 · Cited by 109 · see citing works
Marine Biodiversity in the Australian Region
Butler, A. J., Rees, T., Beesley, P., & Bax, N. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011831 · Cited by 106 · see citing works
Sesterterpenes from Spongia idia
Walker, R. P., Thompson, J. E., & Faulkner, D. J. (1980) · The Journal of Organic Chemistry · doi:10.1021/jo01312a032 · Cited by 104 · see citing works
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitro
Jones, R., Sharkis, S. J., Miller, C., Rowinsky, E. K., Burke, P., & May, W. S. (1990) · Blood · doi:10.1182/blood.v75.6.1319.bloodjournal7561319 · Cited by 98 · see citing works
Pettit, G. R., McNulty, J., Herald, D. L., et al. (1997) · Journal of Natural Products · doi:10.1021/np9606106 · Cited by 98 · see citing works
Zhao, H., Liu, H., Chen, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1382 · Cited by 98 · see citing works
MCL-1 expression in B-cell non-Hodgkin’s lymphomas
Cho‐Vega, J. H., Rassidakis, G. Z., Admirand, J. H., Oyarzo, M. P., Ramalingam, P., Paraguya, A., McDonnell, T. J., Amin, H. M., & Medeiros, L. J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.018 · Cited by 97 · see citing works
Schumacher, M. M., Cerella, C., Eifes, S., Chateauvieux, S., Morceau, F., Jaspars, M., Dicato, M. A., & Diederich, M. F. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.027 · Cited by 95 · see citing works
Self-citationGSK-3 inhibitors induce chromosome instability
Tighe, A., Ray‐Sinha, A., Staples, O. D., & Taylor, S. S. (2007) · BMC Cell Biology · doi:10.1186/1471-2121-8-34 · Cited by 94 · see citing works
Kwan, J. C., Teplitski, M., Gunasekera, S. P., Paul, V. J., & Luesch, H. (2010) · Journal of Natural Products · doi:10.1021/np900614n · Cited by 93 · see citing works
Makaluvamine G, a cytotoxic pigment from an an Indonesian Sponge Histodermella sp.
Carney, J. R., Scheuer, P. J., & Kelly‐Borges, M. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)96256-8 · Cited by 90 · see citing works
Hassan, H. M., Khanfar, M. A., Elnagar, A. Y., et al. (2010) · Journal of Natural Products · doi:10.1021/np900787p · Cited by 87 · see citing works
Shen, S., Zhang, P., Lovchik, M. A., Li, Y., Tang, L.-Y., Chen, Z., Zeng, R., Ma, D., Yuan, J., & Yu, Q. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200810183 · Cited by 83 · see citing works
Pollack, V. A., Álvarez, E., Tse, K. F., Torgov, M. Y., Xie, S., Shenoy, S. G., MacDougall, J. R., Arrol, S., Zhong, H., Gerwien, R. W., et al. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0490-z · Cited by 80 · see citing works
A β-Carboline Alkaloid from the Papua New Guinea Marine Sponge Hyrtios reticulatus
Inman, W. D., Bray, W. M., Gassner, N. C., et al. (2009) · Journal of Natural Products · doi:10.1021/np9005426 · Cited by 78 · see citing works
Dong, Z., Nemeth, J. A., Cher, M. L., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1358 · Cited by 77 · see citing works
Andersson, Y., Juell, S., & Fodstad, Ø. (2004) · International Journal of Cancer · doi:10.1002/ijc.20371 · Cited by 76 · see citing works
Lee, N. Y., Ermakova, S. P., Zvyagintseva, T. N., Kang, K. W., Dong, Z., & Choi, H. S. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.01.025 · Cited by 75 · see citing works
Kuznetsov, G., TenDyke, K., Towle, M. J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0301 · Cited by 72 · see citing works
Molecular pharmacology and antitumor activity of Zalypsis® in several human cancer cell lines
Martínez-Leal, J. F., García-Hernández, V., Moneo, V., Domingo, A., Bueren‐Calabuig, J. A., Negri, A., Gago, F., Guillen-Navarro, M. J., Avilés, P., Cuevas, C., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.003 · Cited by 71 · see citing works
Inhibition of tumor cell invasion and angiogenesis by motuporamines.
Roskelley, C. D., Williams, D. E. J., McHardy, L. M., et al. (2001) · PubMed · Cited by 71 · see citing works
Ascididemin and meridine stabilise G-quadruplexes and inhibit telomerase in vitro
Guittat, L., Cian, A. D., Rosu, F., et al. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.04.023 · Cited by 69 · see citing works
Heteronemin, a new scalarin type sesterterpene from the sponge
Kazlauskas, R. J., Murphy, P. T., Quinn, R. J., et al. (1976) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)91753-2 · Cited by 67 · see citing works
Sceptrin, a Marine Natural Compound, Inhibits Cell Motility in a Variety of Cancer Cell Lines
Ciprés, A., O’Malley, D. P., Li, K., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb900240k · Cited by 67 · see citing works
Ainslie, R. D., Barchi, J. J., Kuniyoshi, M., Moore, R. E., & Mynderse, J. S. (1985) · The Journal of Organic Chemistry · doi:10.1021/jo00216a009 · Cited by 66 · see citing works
New Cytotoxic N -Methylated β-Carboline Alkaloids from the Marine Ascidian Eudistoma g ilboverde
Rashid, M. A., Gustafson, K. R., & Boyd, M. R. (2001) · Journal of Natural Products · doi:10.1021/np010214+ · Cited by 60 · see citing works
Catassi, A., Cesario, A., Arzani, D., Menichini, P., Alama, A., Bruzzo, C., Imperatori, A. S., Rotolo, N., Granone, P. L., & Russo, P. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6264-7 · Cited by 60 · see citing works
Antitubercular Sesterterpenes from the Thai Sponge Brachiaster sp.
Wonganuchitmeta, S.-N., Yuenyongsawad, S., Keawpradub, N., et al. (2004) · Journal of Natural Products · doi:10.1021/np0498354 · Cited by 60 · see citing works
Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer
Klotz, T., Bloch, W., Jacobs, G., et al. (1999) · Urology · doi:10.1016/s0090-4295(99)00212-5 · Cited by 59 · see citing works
Ciucci, A., Gianferretti, P., Piva, R., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025759 · Cited by 58 · see citing works
Grant, S., & Roberts, J. D. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00141-3 · Cited by 57 · see citing works
Guzmán, E. A., Johnson, J. D., Linley, P. A., Gunasekera, S. E., & Wright, A. E. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9422-6 · Cited by 57 · see citing works
Oh, H., Jensen, P. R., Murphy, B. T., et al. (2010) · Journal of Natural Products · doi:10.1021/np1000889 · Cited by 56 · see citing works
Agelasine G, a New Antileukemic Alkaloid from the Okinawan Marine Sponge Agelas sp.
Ishida, K., Ishibashi, M., Shigemori, H., et al. (1992) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.40.766 · Cited by 56 · see citing works
Ray, A., Okouneva, T., Manna, T. K., Miller, H. P., Schmid, S. M., Arthaud, L. E., Ludueña, R. F., Jordan, M. A., & Wilson, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3065 · Cited by 55 · see citing works
Targeting glycogen synthase kinase-3 in insulin signalling
Frame, S., & Zheleva, D. I. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.429 · Cited by 54 · see citing works
Cyclopentenone: a special moiety for anticancer drug design
Conti, M. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000231471.54288.00 · Cited by 54 · see citing works
Zheng, L., Yan, X., Han, X., Chen, H., Lin, W., Lee, S., & Wang, X. (2006) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20050176 · Cited by 53 · see citing works
Drug Development for Cancer Chemoprevention: Focus on Molecular Targets
Johnson, K. A., & Brown, P. H. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.05.012 · Cited by 53 · see citing works
You, J., Dai, H., Chen, Z., et al. (2009) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-009-0667-z · Cited by 52 · see citing works
Spongistatin 1: a new chemosensitizing marine compound that degrades XIAP
Schyschka, L., Rudy, A., Jeremias, I., Barth, N. D., Pettit, G. R., & Vollmar, A. M. (2008) · Leukemia · doi:10.1038/leu.2008.146 · Cited by 49 · see citing works
Warabi, K., Hamada, T., Nakao, Y., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja052688r · Cited by 49 · see citing works
Hinterding, K., Knebel, A., Herrlich, P., & Waldmann, H. (1998) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(98)00070-4 · Cited by 48 · see citing works
Peloruside A enhances apoptosis in H-ras-transformed cells and is cytotoxic to proliferating T cells
Miller, J. H., Rouwé, B., Gaitanos, T. N., et al. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000045789.54694.cf · Cited by 45 · see citing works
Antineoplastic agents. 168. Isolation and structure of axinohydantoin
Pettit, G. R., Herald, C. L., Leet, J. E., et al. (1990) · Canadian Journal of Chemistry · doi:10.1139/v90-250 · Cited by 45 · see citing works
NF-κB as a therapeutic target in chronic lymphocytic leukemia
López‐Guerra, M., & Colomer, D. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003598930 · Cited by 44 · see citing works
Fedorov, S. N., Shubina, L. K., Bode, A. M., Stonik, V. A., & Dong, Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3723 · Cited by 43 · see citing works
LaBarbera, D. V., & Skibo, E. B. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.016 · Cited by 43 · see citing works
Marine toxins and the cytoskeleton: azaspiracids
Vilariño, N. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06713.x · Cited by 42 · see citing works
Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung, Y., & Chang, Y.-F. (2004) · PubMed · Cited by 41 · see citing works
Ling, Y. H., Aracil, M., Jimeno, J. M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.03.003 · Cited by 41 · see citing works
New Scalaranes from the Nudibranch Glossodoris atromarginata and Its Sponge Prey
Fontana, A., Cavaliere, P., Ungur, N. D., et al. (1999) · Journal of Natural Products · doi:10.1021/np9900932 · Cited by 39 · see citing works
Khanfar, M. A., Youssef, D. T. A., & Sayed, K. A. E. (2009) · ChemMedChem · doi:10.1002/cmdc.200900430 · Cited by 37 · see citing works
Till, M., & Prinsep, M. R. (2009) · Journal of Natural Products · doi:10.1021/np8007655 · Cited by 37 · see citing works
Rothmeier, A. S., Ischenko, I., Joore, J., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-117127 · Cited by 36 · see citing works
Targeting Cellular Proapoptotic Molecules for Developing Anticancer Agents from Marine Sources
Lin, X., Liu, M., Hu, C., et al. (2010) · Current Drug Targets · doi:10.2174/138945010791170824 · Cited by 35 · see citing works
Garrido, L., Zubı́a, E., Ortega, M. J., et al. (2000) · Steroids · doi:10.1016/s0039-128x(99)00083-5 · Cited by 35 · see citing works
Makaluvamines vary in ability to induce dosedependent DNA cleavage via topoisomerase II interaction
Matsumoto, S. S., Haughey, H. M., Schmehl, D. M., et al. (1999) · Anti-Cancer Drugs · doi:10.1097/00001813-199901000-00006 · Cited by 33 · see citing works
Ma, J., Xin, X., Meng, L., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003774 · Cited by 32 · see citing works
Schneiders, U. M., Schyschka, L., Rudy, A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1179 · Cited by 30 · see citing works
Scalarane Sesterterpenes from the Sponge Smenospongia sp.
Song, J., Jeong, W., Wang, N., et al. (2008) · Journal of Natural Products · doi:10.1021/np8003694 · Cited by 29 · see citing works
Antitumor effects of Marginisporum crassissimum (Rhodophyceae), a marine red alga
Hiroishi, S., Sugie, K., Yoshida, T., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00460-8 · Cited by 29 · see citing works
Sallam, A. A., Ramasahayam, S., Meyer, S. A., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.08.057 · Cited by 28 · see citing works
Azacitidine and the beginnings of therapeutic epigenetic modulation
O’Dwyer, K. M., & Maslak, P. G. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.11.1981 · Cited by 28 · see citing works
Heteronemin as a Protein Farnesyl Transferase Inhibitor
Ledroit, V., Debitus, C., Ausseil, F., et al. (2004) · Pharmaceutical Biology · doi:10.1080/13880200490886120 · Cited by 28 · see citing works
Pacheco, M. M., Nishimoto, I. N., Neto, M. M., Mantovani, E., & Brentani, M. M. (2001) · The International Journal of Biological Markers · doi:10.1177/172460080101600109 · Cited by 28 · see citing works
Hsiang, C., & Straus, D. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205293 · Cited by 27 · see citing works
Xie, Y., Liu, L., Huang, X., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086520 · Cited by 27 · see citing works
Khanfar, M. A., & Sayed, K. A. E. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.08.066 · Cited by 26 · see citing works
Development of KRN7000, derived from agelasphin produced by Okinawan sponge
Natori, T., Akimoto, K., Motoki, K., et al. (1997) · Folia Pharmacologica Japonica · doi:10.1254/fpj.110.supplement_63 · Cited by 25 · see citing works
Isolation of C11 Cyclopentenones from Two Didemnid Species, Lissoclinum sp. and Diplosoma sp.
Ogi, T., Margiastuti, P., Teruya, T., et al. (2009) · Marine Drugs · doi:10.3390/md7040816 · Cited by 25 · see citing works
Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo
Pan, Y., Fang, L., Fan, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24959 · Cited by 24 · see citing works
Tang, X., Li, J., Xin, X., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.11.3278 · Cited by 24 · see citing works
Tuominen, F. W., & Kenney, F. T. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90879-0 · Cited by 24 · see citing works
Park, C., Jung, J. H., Kim, N., & Choi, Y. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.1.291 · Cited by 23 · see citing works
The marine compound spongistatin 1 targets pancreatic tumor progression and metastasis
Rothmeier, A. S., Schneiders, U. M., Wiedmann, R. M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25241 · Cited by 22 · see citing works
Boonananwong, S., Kongkathip, B., & Kongkathip, N. (2008) · Steroids · doi:10.1016/j.steroids.2008.04.013 · Cited by 21 · see citing works
Park, C., Kim, G., Kim, W. I., Hong, S. H., Park, D. I., Kim, N. D., Bae, S.-J., Jung, J. H., & Choi, Y. H. (2007) · Chemotherapy · doi:10.1159/000100809 · Cited by 21 · see citing works
The Place for Eribulin in the Treatment of Metastatic Breast Cancer
Gradishar, W. J. (2010) · Current Oncology Reports · doi:10.1007/s11912-010-0145-9 · Cited by 21 · see citing works
Study of a renal microsomal inhibitor of hepatic cholesterol synthesis in intact cell systems.
Haven, G. T., Krzemien, J. R., & Nguyen, T. (1973) · PubMed · Cited by 21 · see citing works
Hoang, H., LaBarbera, D. V., Mohammed, K. A., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0700870 · Cited by 20 · see citing works
Telomerase inhibiting activity in vitro from natural resources, marine algae extracts
兼川一典, Harada, H., Myouga, H., Katakura, Y., Shirahata, S., & Kamei, Y. (2000) · Cytotechnology · doi:10.1023/a:1008179302906 · Cited by 19 · see citing works
Xiong, S., Pang, H., Fan, J., Ge, F., Yang, X., Liu, Q., Liao, X., & Xu, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00573.x · Cited by 18 · see citing works
Park, C., Kim, G., Kim, G., et al. (2006) · Oncology Reports · doi:10.3892/or.16.1.171 · Cited by 18 · see citing works
Watanabe, J., Natsume, T., & Kobayashi, M. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280dce1d1 · Cited by 18 · see citing works
Austin, P., Heller, M., Williams, D. E., McIntosh, L. P., Vogl, A. W., Foster, L. J., Andersen, R. J., Roberge, M., & Roskelley, C. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010836 · Cited by 15 · see citing works
The possible role of TNF-? and IL-2 in inducing tumor-associated metabolic alterations
Noguchi, Y., Makino, T., Yoshikawa, T., et al. (1996) · Surgery Today · doi:10.1007/bf00311989 · Cited by 14 · see citing works
Inhibitory effect of a marine microalgal polysaccharide on the telomerase activity in K562 cells.
Sogawa, K., Sumida, T., Hamakawa, H., et al. (1998) · PubMed · Cited by 14 · see citing works
Conti, M. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.9.1153 · Cited by 13 · see citing works
Berenson (2001) · doi:10.1002/1097-0142(20010401)91:7
Flagged first, then by citations
Cited by
Sorted by citations
Microalgae in modern cancer therapy: current knowledge
Abd El-Hack, M. E., Abdelnour, S., Alagawany, M., Abdo, M., Sakr, M. A., Khafaga, A. F., Mahgoub, S. A., Elnesr, S. S., & Gebriel, M. G. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.069 · Cited by 206 · see citing works
Anticancer and Cancer Preventive Properties of Marine Polysaccharides: Some Results and Prospects
Fedorov, S., Ermakova, S., Zvyagintseva, T., & Stonik, V. (2013) · Marine Drugs · doi:10.3390/md11124876 · Cited by 189 · see citing works
Anti-Inflammatory and Anticancer Drugs from Nature
Orlikova, B., Legrand, N., Panning, J., Dicato, M., & Diederich, M. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_8 · Cited by 108 · see citing works
Self-citationGreen analytical methodologies for the discovery of bioactive compounds from marine sources
Duarte, K., Justino, C. I. L., Pereira, R., Freitas, A. C., Gomes, A. M., Duarte, A. C., & Rocha-Santos, T. A. P. (2014) · Trends in Environmental Analytical Chemistry · doi:10.1016/j.teac.2014.11.001 · Cited by 21 · see citing works
Bioactive compounds from marine yeast inhibits lung cancer
Sekar, M., Poomalai, S., Gunasekaran, M., Mani, P., & Krishnamurthy, A. (2015) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2015.58.s2 · Cited by 8 · see citing works
- Authors
- Schumacher, M., Kelkel, M., Dicato, M., & Diederich, M.
- Affiliations
- Hôpital Kirchberg (LU)
- Corresponding author
- Diederich, Marc
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 29
- Issue
- 5
- Pages
- 531-547
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2001546125
- Cited by
- 138
- References
- 169
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 9 · 2020: 12 · 2019: 6 · 2018: 10 · 2017: 11 · 2016: 8 · 2015: 13 · 2014: 16 · 2013: 14 · 2012: 10
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biotechnology Advances (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonds National de la Recherche Luxembourg
- Fondation Recherche Cancer et Sang
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Marine Sponges and Natural Products
- Health Sciences › Medicine › Pharmacology › Microbial Natural Products and Biosynthesis
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Keywords
- marine natural products, anticancer agents, cancer hallmarks, chemoprevention, anticancer activity, angiogenesis, metastasis, tissue invasion, marine organisms
- MeSH terms
- Animals, Antineoplastic Agents, Biological Products, Biotechnology, Humans, Neoplasm Metastasis, Neovascularization, Pathologic, Apoptosis, Cell Growth Processes, Drug Discovery, Aquatic Organisms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review